Are Unlisted Shares a Good Investment? Risks and Safety Checklist

A first-time investor's guide to the real risks of unlisted shares, how to tell a trustworthy platform from a bad one, and what to check before you pay.

Last reviewed on 28 August 2026

"Is it good to buy unlisted shares?" is the most common question we receive from readers who have never bought private stock before. The honest answer is: sometimes, for some investors, in small amounts, and only after checking a specific list of things. This page explains the risks that matter most, how to vet the platform or seller you are dealing with, and then gives you a checklist to run before any money moves.

If you are not yet sure what unlisted shares are, start with What Are Unlisted Shares?. If you already know and want the mechanics of a purchase, the how-to-buy guide covers the full process.

Are Unlisted Shares a Good Investment?

Unlisted shares are neither a scam nor a shortcut. They are a legitimate asset class with a specific risk profile. They tend to make sense when all of the following are true:

  • You qualify as an accredited investor — most reputable US platforms will not deal with you otherwise.
  • You can leave the money untouched for five to ten years. There is no reliable way to sell on short notice.
  • The amount is small enough that a total loss would not change your financial plans. A common rule of thumb among advisers is to keep private investments to 5–10% of investable assets, spread across several companies.
  • You can actually get information about the company — recent financials, the cap table, the share class you are buying — and are willing to read it.
  • You understand that the price you pay is negotiated, not quoted, and may be well above or below what the shares are "worth".

They tend to be a poor fit when the money may be needed for a house, education, or retirement within a few years; when the investment would be a large share of your net worth; when the offer arrived unsolicited; or when you cannot independently verify anything about the company or the seller.

The Risks That Actually Hurt First-Time Investors

Every guide lists "illiquidity" and "risk of loss". Those are real, but in practice first-time buyers are hurt most by a narrower set of problems:

1. Paying a premium over the last round price

Popular companies frequently trade on secondary markets at a premium to their last funding-round valuation, sometimes 30–50% or more. A premium is not automatically wrong, but it means the company must grow into a higher valuation before you break even, and it leaves you exposed if the next round is flat or down. Always ask what the last preferred-round price per share was, what the most recent 409A valuation of common stock is, and where recent secondary trades cleared. Our valuation guide explains how to interpret those three numbers together.

2. Buying the wrong share class

Common stock and preferred stock in the same company can be worth very different amounts at exit because of liquidation preferences. Secondary buyers usually receive common stock (or an interest in a vehicle that holds common). If you are paying a preferred-round price for common shares, you are paying for rights you will not get.

3. Not owning what you think you own

Many secondary purchases are structured through an SPV or a forward contract rather than a direct transfer of shares. In an SPV you own a unit of a fund that owns the shares; in a forward contract you own a promise from an employee to deliver shares or proceeds later. Both can be perfectly legitimate, but each adds fees, counterparty risk, and a layer between you and the company. Know which structure you are entering and read its documents.

4. Fees that eat the return

Platform fees of 3–5% on each side, SPV setup and annual management fees, carried interest of up to 20% on gains, and transfer-agent and legal costs can together consume a meaningful slice of the return. The all-in cost of a secondary transaction page itemises these; get every fee in writing before you commit.

5. The company blocks or delays the transfer

Almost all private companies have a right of first refusal and transfer-approval process. A transaction can be delayed for months or cancelled outright after you have committed. Reputable platforms will tell you how often a given company has approved prior transfers.

6. Fraud and misrepresentation

Because there is no exchange and no public price, the private market attracts a minority of bad actors: sellers who do not actually hold the shares, intermediaries who inflate prices, and outright fake offerings of shares in well-known private companies. The vetting steps below are designed to screen these out.

7. Regulatory and tax surprises

Shares acquired privately are restricted securities under US law, with holding periods before resale. If the company later goes public, you will almost certainly face an IPO lock-up before you can sell. And the tax treatment — including whether you might qualify for the QSBS exclusion — depends on how and when you acquired the shares.

How to Tell Whether a Platform or Seller Is Trustworthy

Readers often ask for a "credibility rating" of unlisted share providers. No such official rating exists, but a short set of checks separates established, regulated venues from the rest:

  • Regulatory registration. In the United States, a platform that arranges securities transactions should operate through a broker-dealer registered with FINRA and the SEC. Look up the firm and the individual you are dealing with on FINRA BrokerCheck and the SEC's Investment Adviser Public Disclosure database. If a firm claims to be registered but you cannot find it, stop.
  • Where the money sits. Your funds should go to an escrow agent or a segregated custody account, never to the platform's operating account or to an individual. Ask for the escrow agreement.
  • Evidence of the shares. A legitimate seller can produce a stock certificate, a transfer-agent statement, or a cap-table entry from a system such as Carta. A platform should have verified this before listing.
  • Company involvement. Ask whether the company has approved prior transfers from this seller or platform, and what its ROFR process looks like. A platform that cannot answer has not done the transaction before.
  • Written fee disclosure. Every fee — platform, SPV, carry, legal, transfer agent — should be in a document you receive before you sign. Fees revealed at closing are a red flag.
  • Track record. How long has the platform operated, roughly how many transactions has it completed, and is it referenced by institutional investors or mainstream financial press? The platform comparison profiles the major US venues.
  • Behaviour. Unsolicited outreach, pressure to wire within days, "guaranteed" allocation or returns, requests to pay in cryptocurrency, and refusal to share documents until after a deposit are the classic patterns in private-share fraud.

A note on unregulated markets. In some countries, unlisted shares are sold by unregulated dealers directly to retail investors at whatever price the dealer sets. The checks above still apply in spirit — verify the dealer's regulatory status with your national securities regulator, verify the shares exist, and never pay an individual's personal account — but be aware that investor protections, disclosure, and recourse can be far weaker than in a regulated US secondary transaction.

First-Time Investor Checklist: Run This Before You Pay

Work through every item. If you cannot tick one, treat that as the answer.

About you

  • I meet the accredited investor tests and can document it.
  • I can hold this investment for at least five years without needing the money.
  • This purchase is a small percentage of my investable assets, and I am not borrowing to fund it.
  • I have decided in advance what I would do if the company raised a down round, was acquired for less than my price, or stayed private for ten years.

About the platform or seller

  • I have verified the broker-dealer or adviser on FINRA BrokerCheck / SEC IAPD (or my national regulator's register).
  • Funds will be held in escrow or segregated custody, and I have seen the agreement.
  • I have seen evidence that the seller holds the shares.
  • I have a complete written fee schedule.
  • I was not approached unsolicited and am not being rushed.

About the shares

  • I know exactly what I am buying: direct common stock, preferred stock, an SPV unit, or a forward contract.
  • I know the last preferred-round price per share, the most recent 409A price, and recent secondary trade prices, and I understand why my price differs from each.
  • I have a copy of, or a reliable summary of, the cap table including liquidation preferences ahead of my shares.
  • I know whether the company must approve the transfer, how long that typically takes, and how often it has refused.
  • I have the subscription or purchase documents and have read the transfer restrictions.

About the company

  • I have seen recent financial information — revenue, growth, burn, and runway — not just a headline valuation.
  • I have a realistic view of the exit path and its timing, and I have not relied on an IPO date that keeps slipping.
  • I have worked through the fuller pre-IPO due diligence checklist.

About the exit and taxes

  • I understand that the shares are restricted and that an IPO would bring a lock-up period before I can sell.
  • I have recorded my purchase date and cost basis and understand the tax treatment of an eventual sale.

How Much Money Do You Need?

On the major US secondary platforms, minimum investments are typically $10,000–$25,000 (EquityZen, Hiive), $100,000+ (Forge Global), and $250,000+ for institutional venues such as Zanbato. On top of the purchase price, budget for platform fees (commonly 3–5%) and, where an SPV is used, setup and annual fees. Because a sensible allocation is spread across several companies and kept to a small share of your portfolio, the practical minimum for a diversified private-share allocation is considerably higher than any single platform's floor.

Bottom Line

Unlisted shares can be a good investment for a patient, accredited investor who buys the right share class, at a price they understand, through a regulated venue, in an amount they can afford to lose. They are a bad investment for anyone who cannot say yes to every part of that sentence. The checklist above exists so that the difference is settled before the wire goes out — not years later at the exit.